These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

469 related articles for article (PubMed ID: 19181773)

  • 1. Characterization of tumefactive demyelinating lesions using MR imaging and in-vivo proton MR spectroscopy.
    Malhotra HS; Jain KK; Agarwal A; Singh MK; Yadav SK; Husain M; Krishnani N; Gupta RK
    Mult Scler; 2009 Feb; 15(2):193-203. PubMed ID: 19181773
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Conventional and advanced magnetic resonance imaging in tumefactive demyelination.
    Saini J; Chatterjee S; Thomas B; Kesavadas C
    Acta Radiol; 2011 Dec; 52(10):1159-68. PubMed ID: 22025739
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of possible prognostic factors of fulminant acute disseminated encephalomyelitis (ADEM) on magnetic resonance imaging with fluid-attenuated inversion recovery (FLAIR) and diffusion-weighted imaging.
    Donmez FY; Aslan H; Coskun M
    Acta Radiol; 2009 Apr; 50(3):334-9. PubMed ID: 19235577
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Proton magnetic resonance spectroscopy and diffusion-weighted imaging in intracranial cystic mass lesions.
    Lai PH; Hsu SS; Ding SW; Ko CW; Fu JH; Weng MJ; Yeh LR; Wu MT; Liang HL; Chen CK; Pan HB
    Surg Neurol; 2007; 68 Suppl 1():S25-36. PubMed ID: 17963918
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The role of quantitative neuroimaging indices in the differentiation of ischemia from demyelination: an analytical study with case presentation.
    Hoque R; Ledbetter C; Gonzalez-Toledo E; Misra V; Menon U; Kenner M; Rabinstein AA; Kelley RE; Zivadinov R; Minagar A
    Int Rev Neurobiol; 2007; 79():491-519. PubMed ID: 17531856
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Atypical idiopathic inflammatory demyelinating lesions (IIDL): conventional and diffusion-weighted MR imaging (DWI) findings in 42 cases.
    Koelblinger C; Fruehwald-Pallamar J; Kubin K; Wallner-Blazek M; van den Hauwe L; Macedo L; Puchner SB; Thurnher MM
    Eur J Radiol; 2013 Nov; 82(11):1996-2004. PubMed ID: 23993757
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Central nervous system lymphoma characterization by diffusion-weighted imaging and MR spectroscopy.
    Zacharia TT; Law M; Naidich TP; Leeds NE
    J Neuroimaging; 2008 Oct; 18(4):411-7. PubMed ID: 18494774
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of diffusion-weighted MR in differential diagnosis of intracranial cystic lesions.
    Bükte Y; Paksoy Y; Genç E; Uca AU
    Clin Radiol; 2005 Mar; 60(3):375-83. PubMed ID: 15710142
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dysembryoplastic neuroepithelial tumors: magnetic resonance imaging and magnetic resonance spectroscopy evaluation.
    Yu AH; Chen L; Li YJ; Zhang GJ; Li KC; Wang YP
    Chin Med J (Engl); 2009 Oct; 122(20):2433-7. PubMed ID: 20079155
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Performance of Apparent Diffusion Coefficient Values and Conventional MRI Features in Differentiating Tumefactive Demyelinating Lesions From Primary Brain Neoplasms.
    Mabray MC; Cohen BA; Villanueva-Meyer JE; Valles FE; Barajas RF; Rubenstein JL; Cha S
    AJR Am J Roentgenol; 2015 Nov; 205(5):1075-85. PubMed ID: 26496556
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Conspicuity of diffuse axonal injury lesions on diffusion-weighted MR imaging.
    Kinoshita T; Moritani T; Hiwatashi A; Wang HZ; Shrier DA; Numaguchi Y; Westesson PL
    Eur J Radiol; 2005 Oct; 56(1):5-11. PubMed ID: 16168258
    [TBL] [Abstract][Full Text] [Related]  

  • 12. T2-hyperintense foci on brain MR imaging.
    Bekiesińska-Figatowska M
    Med Sci Monit; 2004 Jun; 10 Suppl 3():80-7. PubMed ID: 16538206
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mass lesions in the brain: tumor or multiple sclerosis? Clinical and imaging characteristics and course from a single reference center.
    Kilic AK; Kurne AT; Oguz KK; Soylemezoglu F; Karabudak R
    Turk Neurosurg; 2013; 23(6):728-35. PubMed ID: 24310455
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reversible inferior colliculus lesion in metronidazole-induced encephalopathy: magnetic resonance findings on diffusion-weighted and fluid attenuated inversion recovery imaging.
    Lee SS; Cha SH; Lee SY; Song CJ
    J Comput Assist Tomogr; 2009; 33(2):305-8. PubMed ID: 19346865
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Paediatric PNET: pre-surgical MRI features.
    Chawla A; Emmanuel JV; Seow WT; Lou J; Teo HE; Lim CC
    Clin Radiol; 2007 Jan; 62(1):43-52. PubMed ID: 17145263
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Spectroscopic magnetic resonance imaging of a tumefactive demyelinating lesion.
    Law M; Meltzer DE; Cha S
    Neuroradiology; 2002 Dec; 44(12):986-9. PubMed ID: 12483443
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Magnetic resonance features of cerebral malaria.
    Yadav P; Sharma R; Kumar S; Kumar U
    Acta Radiol; 2008 Jun; 49(5):566-9. PubMed ID: 18568544
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Metabolite findings in tumefactive demyelinating lesions utilizing short echo time proton magnetic resonance spectroscopy.
    Cianfoni A; Niku S; Imbesi SG
    AJNR Am J Neuroradiol; 2007 Feb; 28(2):272-7. PubMed ID: 17296993
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of MRI in the differentiation of ADEM from MS in children.
    Callen DJ; Shroff MM; Branson HM; Li DK; Lotze T; Stephens D; Banwell BL
    Neurology; 2009 Mar; 72(11):968-73. PubMed ID: 19038851
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of diffusion-weighted magnetic resonance imaging in diffuse axonal injury.
    Ezaki Y; Tsutsumi K; Morikawa M; Nagata I
    Acta Radiol; 2006 Sep; 47(7):733-40. PubMed ID: 16950714
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.